Skip to main content

Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
In Person Only
In Person Only
Location: Hilton San Diego Bayfront
Location: Hilton San Diego Bayfront

Abstracts

Abstracts

  • Sunday, October 1, 2023
  • 8:00 AM – 8:07 AM PT
    100 - Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk DCIS after Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Base
    Location: Room 6 B

    Presenter: Frank Vicini, MD, FASTRO – GenesisCare

  • 8:10 AM – 8:17 AM PT
    101 - Long Term Outcomes of Radiation (RT)-Monotherapy vs. Combined RT + Endocrine Therapy (RT+ET) in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older after Breast-Conserving Surgery (BCS)
    Location: Room 6 B

    Presenter: Astrid Morris, MD, MS – Tumor Institute Radiation Oncology Group

  • 8:20 AM – 8:27 AM PT
    102 - Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving Surgery
    Location: Room 6 B

    Presenter: Brady Laughlin, MD – Mayo Clinic Arizona

  • 8:30 AM – 8:37 AM PT
    103 - Impact of Neoadjuvant Concurrent Chemoradiation (NACCRT) on Operability and Survival in Locally Advanced Inoperable Breast Cancer
    Location: Room 6 B

    Presenter: Priya Iyer, MD, RT, MBBS – Cancer Institute (WIA)

  • 8:40 AM – 8:47 AM PT
    104 - Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India
    Location: Room 6 B

    Presenter: Rajiv Sarin, MD, FRCR – Tata Memorial Centre

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 6 B

    Discussant: Jean Wright, MD, FASTRO – Johns Hopkins University

  • 8:00 AM – 8:07 AM PT
    110 - STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung Injury
    Location: Room 32

    Presenter: Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University

  • 8:10 AM – 8:17 AM PT
    111 - Early and noninvasive PET imaging of radiation-induced lung injury by targeting CXCR4
    Location: Room 32

    Presenter: Jie Liu, MD – Shandong Anti-Cancer Association

  • 8:20 AM – 8:27 AM PT
    112 - Subacute Cutaneous Toxicity with Single-Fraction Electron FLASH RT in Yorkshire Swine
    Location: Room 32

    Presenter: Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center

  • 8:30 AM – 8:37 AM PT
    113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal Injury
    Location: Room 32

    Presenter: Haiyan Lu, MD – The Second Affiliated Hospital of Soochow University

  • 8:30 AM – 8:37 AM PT
    113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal Injury
    Location: Room 32

    Presenter: Ye Tian, MD – The Second Affiliated Hospital of Soochow University

  • 8:40 AM – 8:47 AM PT
    114 - HDAC-Mediated Glial Crosstalk Mediates Radiation Induced Memory Changes from Whole Brain Radiation in a Mouse Model
    Location: Room 32

    Presenter: Peter Mathen, MD – NIH/NCI

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 32

    Discussant: Deborah Citrin, MD, FASTRO – NIH/NCI

  • 8:00 AM – 8:07 AM PT
    105 - Clinical Validation of HPV ctDNA for Early Detection of Residual Disease Following Chemoradiation in Cervical Cancer
    Location: Room 5

    Presenter: Kathy Han, MD, MS – Princess Margaret Cancer Center, University Health Network

  • 8:10 AM – 8:17 AM PT
    106 - Prognostic Impact of Mismatch Repair Deficiency on Stage I-II Endometrioid Endometrial Cancer Treated with Adjuvant Radiation Therapy: A Multi-Institutional Analysis
    Location: Room 5

    Presenter: Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey

  • 8:20 AM – 8:27 AM PT
    107 - HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation
    Location: Room 5

    Presenter: Aaron Seo, MD, PhD – MD Anderson Cancer Center

  • 8:30 AM – 8:37 AM PT
    108 - A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial Cancer
    Location: Room 5

    Presenter: Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine

  • 8:40 AM – 8:47 AM PT
    109 - Mutational Landscape of ER Receptor Negative Endometrial Cancer Patients Categorized as No Specific Molecular Profile (NSMP)
    Location: Room 5

    Presenter: Michael Waters, MD, PhD – Washington University St. Louis

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 5

    Discussant: Lara Hathout, MD, FRCPC – Rutgers Cancer Institute of New Jersey

  • 8:05 AM – 8:10 AM PT
    1000 - Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results
    Location: Room 8

    Presenter: Peter Hoskin, MD – Mount Vernon Hospital

  • 8:10 AM – 8:15 AM PT
    1002 - Long-Term Outcomes of Prospective Clinical Trial HDR-Brachytherapy Monotherapy in Single Day in Patients with Localizated Prostate Cancer
    Location: Room 8

    Presenter: Elena Moreno-Olmedo, MD – Genesiscare UK (Oxford)

  • 8:15 AM – 8:20 AM PT
    1004 - Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer
    Location: Room 8

    Presenter: Shang-Bin Qin, MD

  • 8:20 AM – 8:25 AM PT
    1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis
    Location: Room 8

    Presenter: Gamze Ugurluer, MD – Acibadem Adana Hospital

  • 8:20 AM – 8:25 AM PT
    1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis
    Location: Room 8

    Presenter: Enis Ozyar, MD – Acibadem Maslak Hospital

  • 8:25 AM – 8:30 AM PT
    1008 - Prospective Comparative Study of Quality of Life in Bladder Cancer Patients Undergoing Cystectomy or Bladder Preservation
    Location: Room 8

    Presenter: Vedang Murthy, MD – Tata Memorial Centre

  • 8:30 AM – 8:40 AM PT
    1010 - Prognostication of Overall Survival in Muscle Invasive Bladder Cancer: An Application of a Lymph Node Metastasis Nomogram
    Location: Room 8

    Presenter: Garrett Harada, MD – UCI Health

  • 9:30 AM – 9:40 AM PT
    3 - Consolidative Radiotherapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab Vedoti
    Location: Ballroom 20

    Presenter: Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida

  • 9:40 AM – 9:50 AM PT
    4 - Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer Survivors
    Location: Ballroom 20

    Presenter: Kathrin Kirchheiner, PhD, MSc – Medical University of Vienna

  • 9:50 AM – 10:00 AM PT
    5 - TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II)
    Location: Ballroom 20

    Presenter: Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre

  • 10:00 AM – 10:10 AM PT
    6 - Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
    Location: Ballroom 20

    Presenter: W. Robert Lee, MD, MS, FASTRO, MEd – Duke University Medical Center

  • 10:10 AM – 10:20 AM PT
    7 - Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2Gy) vs. Standard Dose (70.2Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer
    Location: Ballroom 20

    Presenter: Jeff Michalski, MD, MBA, FASTRO – Washington University St. Louis

  • 10:20 AM – 10:30 AM PT
    Discussant
    Location: Ballroom 20

    Discussant: Dayssy Diaz Pardo, MD, MS – The Ohio State University

  • 10:20 AM – 10:30 AM PT
    LBA 05 - Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy After Implant-Based Rec
    Location: Ballroom 20

    Presenter: Rinaa Punglia, MD, FASTRO, MPH – Dana-Farber Cancer Institute

  • 10:30 AM – 10:40 AM PT
    LBA 06 - Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup Analysis
    Location: Ballroom 20

    Presenter: Swetha Sridharan, MBBS – Calvary Mater Newcastle Hospital

  • 10:40 AM – 10:50 AM PT
    LBA 07 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial
    Location: Ballroom 20

    Presenter: Denise Bernhardt, MD – Technical University of Munich (TUM), Radiation Oncology

  • 4:50 PM – 4:55 PM PT
    1012 - Development and Evaluation of a Mobile App for Radiotherapy Patient Education
    Location: Room 8

    Presenter: Jose Felipe Munoz Lozano, MD – Hospital Universitario

  • 4:55 PM – 5:00 PM PT
    1014 - Association of Parental Status and Gender with Burden of Multidisciplinary Tumor Boards
    Location: Room 8

    Presenter: Brittney Chau, MD – USC

  • 5:00 PM – 5:05 PM PT
    1016 - Teaching Trainees to be Effective Mentors: A Needs-Based Assessment in Radiation Oncology
    Location: Room 8

    Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber

  • 5:05 PM – 5:10 PM PT
    1018 - Quality of Life In Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac
    Location: Room 8

    Presenter: Sara Beltran Ponce, MD – Medical College of Wisconsin

  • 5:10 PM – 5:15 PM PT
    1020 - A Randomized Standard-of-Care Controlled Trial of Xenogeneic Platelet-Rich Plasma Lotion to Reduce Acute Radiation Dermatitis in Breast Cancer Patients
    Location: Room 8

    Presenter: Chun-Shu Lin, MD, PhD – Tri-Service General Hospital

  • 5:15 PM – 5:20 PM PT
    1022 - Harnessing Electronic Patient-Reported Outcomes (ePRO) in Routine Care to Promote Clinical Trial Enrollment: A Randomized Study
    Location: Room 8

    Presenter: Nicholas Verdini, BS – Tufts University School of Medicine

  • 4:45 PM – 4:52 PM PT
    115 - Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-Gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm Trial
    Location: Room 1

    Presenter: Pooja Karukonda, MD – Duke Cancer Institute

  • 4:55 PM – 5:02 PM PT
    116 - Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal Cancer
    Location: Room 1

    Presenter: Yufei Liu, MD, PhD – City of Hope

  • 5:05 PM – 5:12 PM PT
    117 - Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical Trial
    Location: Room 1

    Presenter: Yang Yang, MD, DO, PhD – Zhejiang Cancer Hospital

  • 5:15 PM – 5:22 PM PT
    118 - Electrocardiogram with Artificial Intelligence Assessment as a Predictor of Cardiac Events and Overall Survival in Patients Receiving Radiotherapy for Esophageal Cancer
    Location: Room 1

    Presenter: Roman Kowalchuk, MD, BS – Mayo Clinic College of Medicine and Science Rochester

  • 5:25 PM – 5:32 PM PT
    119 - Utilization of the Triangle Volume in Patients with Localized PDAC Undergoing Pre-Operative SBRT: Report of Early Outcomes
    Location: Room 1

    Presenter: Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center

  • 5:35 PM – 5:42 PM PT
    120 - Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer
    Location: Room 1

    Presenter: Michael Chuong, MD – Miami Cancer Institute

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 1

    Discussant: Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center

  • 4:45 PM – 4:52 PM PT
    127 - Deep Learning-Based Natural Language Processing to Automate Esophagitis Severity Grading from the Electronic Health Records
    Location: Room 32

    Presenter: Shan Chen, MS – Harvard Medical School

  • 4:55 PM – 5:02 PM PT
    128 - Operational Ontology for Radiation Oncology (OORO): A Professional Society-Based, Multi-Stakeholder Consensus Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data
    Location: Room 32

    Presenter: Amanda Caissie

  • 5:05 PM – 5:12 PM PT
    129 - A Prospective Study of Machine Learning-Assisted Radiotherapy Planning for Patients Receiving 54 Gy to the Brain
    Location: Room 32

    Presenter: Derek Tsang, MD, MS – Princess Margaret Cancer Centre

  • 5:15 PM – 5:22 PM PT
    130 - Curietherapy User eXperience Pilot Study: A Novel Augmented Reality Educational Tool during Radiation Oncology Consultation for Patients with Breast Cancer
    Location: Room 32

    Presenter: David Byun, MD – NYU Grossman School of Medicine

  • 5:25 PM – 5:32 PM PT
    131 - Improving Dose Volume Histogram (DVH) Based Analysis of Clinical Outcomes Using Modern Statistical Techniques: A Systematic Answer to Multiple Comparisons Concerns
    Location: Room 32

    Presenter: Mirek Fatyga, PhD – Mayo Clinic Arizona

  • 5:35 PM – 5:42 PM PT
    132 - Clinical Acceptability of Artificial Intelligence-Screened Interstitial Lung Disease (AI-ILD) in Lung Cancer Patients Treated with Radiotherapy
    Location: Room 32

    Presenter: Nicholas McNeil, MBBS – University of Toronto

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 32

    Discussant: Danielle Bitterman, MD – Brigham and Women's Hospital

  • 4:45 PM – 4:52 PM PT
    121 - Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented Populations
    Location: Room 4

    Presenter: Kekoa Taparra, MD, PhD – Stanford Health Care

  • 4:55 PM – 5:02 PM PT
    122 - The Impact of a Precision Medicine Navigator on Inequities Associated with Utilization of Genomic Tests in Black Men with Prostate Cancer
    Location: Room 4

    Presenter: Alexander Allen, MD – University of Maryland Medical Center

  • 5:05 PM – 5:12 PM PT
    123 - Improving Sexual Orientation and Gender Identity Documentation at an NCI-Designated Comprehensive Cancer Center
    Location: Room 4

    Presenter: Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center

  • 5:15 PM – 5:22 PM PT
    124 - State Mandatory Paid Family Leave and Survival among Children with Cancer
    Location: Room 4

    Presenter: Justin Barnes, MD, MS – Washington University School of Medicine

  • 5:25 PM – 5:32 PM PT
    125 - Under-Representation for Female Cancers in Commercial Auto-Segmentation Solutions and Open-Source Imaging Datasets
    Location: Room 4

    Presenter: Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center

  • 5:35 PM – 5:42 PM PT
    126 - Impact of Free Hospital-Provided Rideshare Service on Radiation Therapy Completion Rates: A Matched Cohort Analysis
    Location: Room 4

    Presenter: Eric Chen, MD – University Hospitals Seidman Cancer Center

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 4

    Discussant: Idalid Franco, MD, MPH – Dana-Farber/Brigham and Women's Cancer Center